Do We Have Sufficient Evidence to Define Prognosis for “Low-grade” Fumarate Hydratase–deficient Renal Cell Carcinoma?
Advances in Anatomic Pathology | February 24, 2022 | Volume: 29 | Issue: 3 | Pages: 178-181
10.1097/pap.0000000000000335
| PMID 35200165